Coquitlam, Canada

Hossein Pajouhesh

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 194(Granted Patents)


Location History:

  • Burnaby, CA (2005 - 2009)
  • Coquitlam, CA (2009 - 2019)

Company Filing History:


Years Active: 2005-2019

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Hossein Pajouhesh: Innovating Sodium Channel Inhibition

Introduction

Hossein Pajouhesh is a notable inventor based in Coquitlam, Canada, recognized for his significant contributions to the field of pharmacology through his innovative inventions. With a prolific portfolio of 14 patents, his work primarily focuses on compounds that play a crucial role in treating diseases associated with voltage-gated ion channel functions.

Latest Patents

Pajouhesh's latest patents include groundbreaking inventions such as the "Benzimidazole inhibitors of the sodium channel." This invention relates to compounds that are beneficial for treating various conditions linked to sodium channel activity. The compounds described in this patent, particularly those outlined in Formulas (I)-(XIII), including Formula (X) and Compounds (1)-(236) of Table 1, are designed to address a number of diseases.

Another patented innovation is the "Heterocyclic inhibitors of the sodium channel," which encompasses compounds that are used to treat conditions such as epilepsy, cancer, pain, migraine, Parkinson's Disease, mood disorders, schizophrenia, psychosis, tinnitus, amyotrophic lateral sclerosis, glaucoma, ischemia, spasticity disorders, obsessive-compulsive disorder, restless leg syndrome, and Tourette syndrome. The heterocyclic compounds mentioned, particularly those represented in Formulas (I)-(X) and Compounds (1)-(92) of Table 1, highlight the versatility and significance of Pajouhesh’s work.

Career Highlights

Throughout his career, Hossein Pajouhesh has made a lasting impact in the pharmaceutical domain. He has held key roles at prestigious organizations, including Neuromed Pharmaceuticals Ltd. and Neuromed Technologies, Inc. His contributions have not only advanced the scientific community's understanding of sodium channels but have also led to the development of viable treatments for a plethora of debilitating conditions.

Collaborations

Pajouhesh has worked alongside notable colleagues, including Hassan Pajouhesh and Terrance P Snutch. These collaborations have allowed him to leverage diverse expertise and push the boundaries of innovation within the realm of pharmacology.

Conclusion

In conclusion, Hossein Pajouhesh stands out as a pivotal figure in the invention and innovation of sodium channel inhibitors. His extensive portfolio of patents reflects his dedication to improving health outcomes through scientific exploration and application. As he continues to innovate, the impact of his work will surely resonate within the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…